Expanded murine regulatory T cells: Analysis of phenotype and function in contact hypersensitivity reactions

Journal of Immunological Methods

Volumn 326, Issue 1-2, 2007, Pages 10-21

  Ring, Sabine ^a   Thome, Marianne ^a   Pretsch, Leah ^a   Enk, Alexander H ^a   Mahnke, Karsten ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

CHS; Expansion; Treg

Indexed keywords

CD3 ANTIBODY; INTERLEUKIN 2; LIQUID NITROGEN; MOLECULAR MARKER; MONOCLONAL ANTIBODY CD28;

ALLERGIC DISEASE; ANIMAL CELL; ARTICLE; AUTOIMMUNE DISEASE; CD4+ CD25+ T LYMPHOCYTE; CELL CULTURE; CELL FUNCTION; CELL ISOLATION; CONTACT ALLERGY; CONTROLLED STUDY; EDEMA; EX VIVO STUDY; FEMALE; HYPERSENSITIVITY REACTION; IMMUNOLOGICAL TOLERANCE; LYMPHOID ORGAN; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FOLDING; REGULATORY T LYMPHOCYTE; THAWING;

ANIMALS; CELL PROLIFERATION; DERMATITIS, CONTACT; IMMUNOPHENOTYPING; LYMPHOID TISSUE; MICE; MICE, INBRED BALB C; T-LYMPHOCYTES, REGULATORY;

MURINAE;

EID: 34548463435     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2007.06.007     Document Type: Article

References (26)

1. Bacchetta R., Passerini L., Gambineri E., Dai M., Allan S.E., Perroni L., Dagna-Bricarelli F., Sartirana C., Matthes-Martin S., Lawitschka A., Azzari C., Ziegler S.F., Levings M.K., and Roncarolo M.G. Defective regulatory and effector T cell functions in patients with FOXP3 mutations. J. Clin. Invest. 116 (2006) 1713
2. + T cells without reversing their suppressive function. J. Immunol. 175 (2005) 7332
3. Cohen J.L., Trenado A., Vasey D., Klatzmann D., and Salomon B.L. CD4(+)CD25(+) immunoregulatory T Cells: new therapeutics for graft-versus-host disease. J. Exp. Med. 196 (2002) 401
4. + regulatory T cells suppress effector T cell proliferation. Clin. Immunol. 115 (2005) 3
5. + regulatory cell activation and function by dendritic cells. Int. Immunol. 1612 (2004) 1769
6. + T-regulatory cells can markedly inhibit allogenic dendritic cell-stimulated MLR cultures. Blood 104 (2004) 453
7. high regulatory T cells. Blood 104 (2004) 895
8. Hori S., Nomura T., and Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299 (2003) 1057
9. Huehn J., and Hamann A. Homing to suppress: address codes for Treg migration. Trends Immunol. 26 (2005) 632
10. + T regulatory cells. Nat. Immunol. 4 (2003) 337
11. Levings M.K., Sangregorio R., and Roncarolo M.G. Human CD25(+)CD4(+) T regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J. Exp. Med. 193 (2001) 1295
12. + regulatory T cells from nonobese diabetic mice. J. Immunol. 175 (2005) 3053
13. Masteller E.L., Tang Q., and Bluestone J.A. Antigen-specific regulatory T cells - ex vivo expansion and therapeutic potential. Semin. Immunol. 18 (2006) 103
14. Onizuka S., Tawara I., Shimizu J., Sakaguchi S., Fujita T., and Nakayama E. Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor alpha) monoclonal antibody. Cancer Res. 59 (1999) 3128
15. + regulatory T cells suppress contact hypersensitivity reactions by blocking influx of effector T cells into inflamed tissue. Eur. J. Immunol. 36 (2006) 2981
16. Sakaguchi S., Sakaguchi N., Asano M., Itoh M., and Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155 (1995) 1151
17. Scalapino K.J., Tang Q., Bluestone J.A., Bonyhadi M.L., and Daikh D.I. Suppression of disease in New Zealand Black/New Zealand White lupus-prone mice by adoptive transfer of ex vivo expanded regulatory T cells. J. Immunol. 177 (2006) 1451
18. + naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int. Immunol. 10 (1998) 1969
19. Tang Q., Henriksen K.J., Bi M., Finger E.B., Szot G., Ye J., Masteller E.L., McDevitt H., Bonyhadi M., and Bluestone J.A. In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J. Exp. Med. 199 (2004) 1455
20. + T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes. J. Exp. Med. 199 (2004) 1467
21. + regulatory T cells restore normoglycemia in diabetic NOD mice. J. Exp. Med. 204 (2007) 191
22. Taylor P.A., Noelle R.J., and Blazar B.R. CD4(+)CD25(+) immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade. J. Exp. Med. 193 (2001) 1311
23. Taylor P.A., Lees C.J., and Blazar B.R. The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality. Blood 99 (2002) 3493
24. + immunoregulatory T cells prevent graft-versus-host-disease by inhibiting activation/differentiation of pathogenic T cells. J. Immunol. 176 (2006) 1266
25. + regulatory T cells in patients with multiple sclerosis. J. Exp. Med. 199 (2004) 971
26. + regulatory T cells by antigen-processing dendritic cells. J. Exp. Med. 198 (2003) 235